EQIX vs SRPT · P/E 79, rev $5.07B vs rev $1.13B
Equinix Inc (EQIX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the EQIX and SRPT stock pages for the full models.
Not investment advice.